Reference
Government of Canada. Summary Safety Review - Remicade (infliximab) - Health Canada. Internet Document : 23 Jul 2018. Available from: URL: https://hpr-rps.hres.ca/reg-content/summary-safety-review-detail.php?lang=en&linkID=SSR00205
Rights and permissions
About this article
Cite this article
Infliximab linked with risk of blistering skin condition. Reactions Weekly 1713, 2 (2018). https://doi.org/10.1007/s40278-018-49836-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-49836-9